Skip to main content
REGENTIS BIOMATERIALS LTD. logo
SEC Form D filing

REGENTIS BIOMATERIALS LTD.

Biotech · Series A · Regulation D 506(c) · Filed June 25, 2026

Offering amount
$6.5M
Exemption
Reg D 506(c)
Issuer state
Not disclosed
Filing date
June 25, 2026
Signature date
June 25, 2026
CIK
0001912966

Summary

Auto-generated

The issuer's name indicates it operates in the biotechnology sector, developing regenerative biomaterials. It filed for a $6,500,000 Series A offering on June 25, 2026, under Exemption 506(c).

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.